STAT+: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Novo Nordisk appointed Poul Weihrauch, CEO of the Mars candy company, as board observer as it tries to boost its consumer focus
Source
Stat News
Opens original article in a new tab



